1 We used data from 1,105 mothers and their children (median ag
2 We used data from 1,111 Scottish children who were followed a
3 We used data from 100 diverse young adults at a predominantly
4 We used data from 1608 women from a UK cohort who had repeat
5 To do so,
we used data from 167 children participating in the Preschool
6 We used data from 19 Demographic and Health Surveys from 2011
7 We used data from 2 large, prospective cohort studies, the Nu
8 We used data from 2016 to 2018 to build the model and data fr
9 We used data from 273 Beninese women followed throughout preg
10 We used data from 35,133 mother-daughter dyads of the Nurses'
11 We used data from 352,985 participants in the European Prospe
12 To this end,
we used data from 415 maize hybrids evaluated in 4 years of s
13 We used data from 7572 women in the Nulliparous Pregnancy Out
14 We used data from 84 089 adult patients with an in-hospital c
15 sal on patterns of genetic diversity underlying adaptation,
we used data from a globally distributed demographic research
16 We used data from a population-based cohort of 47,714 adults
17 We used data from adult patients who tested positive for COVI
18 We used data from an 18-country survey to explore these issue
19 We used data from clinical trials and literature on tuberculo
20 We used data from Demographic and Health Surveys and Multiple
21 We used data from England, which has a comprehensive, consist
22 We used data from Kantar Worldpanel, a commercial household p
23 We used data from Louisiana's sexually transmitted infection
24 We used data from population-based surveys done in sub-Sahara
25 We used data from seven plant species (Quercus humilis, Querc
26 To achieve this goal,
we used data from six paired eddy-covariance towers over co-l
27 We used data from surveys of 538 plant and animal species ove
28 We used data from the 2016 GB Kantar Fast-Moving Consumer Goo
29 From 2011 to 2016,
we used data from the Agency for Health Care Administration t
30 We used data from the Allen Brain Atlas for replication.
31 We used data from the China Kadoorie Biobank (CKB), a nationw
32 We used data from the city of Barcelona (Spain) for the perio
33 We used data from the Extracorporeal Life Support Organizatio
34 We used data from the Framingham Heart Study Offspring Cohort
35 We used data from the HIV Prevention Trials Network (HPTN) 06
36 For the MR,
we used data from the International Network on Venous Thrombo
37 We used data from the Malmo Osteoarthritis Study (MOA), a sma
38 For this propensity-matched analysis,
we used data from the National Cancer Database, a joint proje
39 For an interrupted time series analysis,
we used data from the National Inpatient Sample, a representa
40 We used data from the nationwide Danish Nurse Cohort on 22,88
41 In this study,
we used data from the Ohio Department of Health for deaths ca
42 We used data from the prospective GTH-AH 01/2010 study to ass
43 We used data from the prospective longitudinal REGARDS cohort
44 We used data from the Society of Thoracic Surgeons/American C
45 We used data from the Taiwan Children Health Study with longi
46 We used data from the UK Biobank to combine polygenic risk sc
47 Here,
we used data from three previously reported randomised contro
48 In this population-based, panel data analysis,
we used data from three waves of the nationally representativ
49 We used data from two time points of the Swiss Cohort Study o
50 We used data from venous thromboembolism prevention trials to